Home LiteratureArticle Details
PMID: 10233844 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Mechanisms of enhanced lung injury during sepsis.

The American journal of pathology ·Vol. 154 ·No. 4 ·1999-04-00 ·Pages 1057-65

Czermak BJ, Breckwoldt M, Ravage ZB, Huber-Lang M, Schmal H, Bless NM, Friedl HP, Ward PA

Abstract

A major complication in sepsis is progressively impaired lung function and susceptibility to intrapulmonary infection. Why sepsis predisposes the lung to injury is not clear. In the current studies, rats were rendered septic by cecal ligation/puncture and evaluated for increased susceptibility to injury after a direct pulmonary insult (deposition of IgG immune complexes or airway instillation of lipopolysaccharide). By itself, cecal ligation/puncture did not produce evidence of lung injury. However, after a direct pulmonary insult, lung injury in septic animals was significantly enhanced. Enhanced lung injury was associated with increased accumulation of neutrophils in lung, enhanced production of CXC chemokines (but not tumor necrosis factor-alpha) in bronchoalveolar lavage fluids, and increased expression of lung vascular intercellular adhesion molecule-1 (ICAM-1). Complement depletion or treatment with anti-C5a abolished all evidence of enhanced lung injury in septic animals. When stimulated in vitro, bronchoalveolar lavage macrophages from septic animals had greatly enhanced CXC chemokine responses as compared with macrophages from sham-operated animals or from septic animals that had been complement depleted. These data indicate that the septic state causes priming of lung macrophages and suggest that enhanced lung injury in the septic state is complement dependent and related to increased production of CXC chemokines.

MeSH Terms
Animals Antibodies, Blocking/pharmacology Antigen-Antibody Complex/pharmacology Bronchoalveolar Lavage Fluid/chemistry,cytology Capillary Permeability/drug effects Chemokines, CXC/biosynthesis Complement C5a/antagonists & inhibitors,immunology Complement Inactivator Proteins/pharmacology Elapid Venoms/pharmacology Immunoglobulin G/pharmacology Intercellular Adhesion Molecule-1/biosynthesis Lipopolysaccharides/pharmacology Lung Diseases/immunology,metabolism,pathology Macrophages, Alveolar/metabolism Male Neutrophils/immunology Rats Rats, Long-Evans Sepsis/complications,immunology Tumor Necrosis Factor-alpha/analysis
Chemicals
Antibodies, Blocking Antigen-Antibody Complex Chemokines, CXC Complement Inactivator Proteins Elapid Venoms Immunoglobulin G Lipopolysaccharides Tumor Necrosis Factor-alpha cobra venom factor Intercellular Adhesion Molecule-1 Complement C5a
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Czermak B J
Department of Trauma Surgery, University of Freiburg Medical School, Freiburg/Breisgau, Germany.
Breckwoldt M
Ravage Z B
Huber-Lang M
Schmal H
Bless N M
Friedl H P
Ward P A
References (33)
33 references, click to expand
  1. Requirement and role of C5a in acute lung inflammatory injury in rats.
    J Clin Invest. 1996 Jul 15;98(2):503-12 PMID: 8755663
  2. Chronological changes in the complement system in sepsis.
    Surg Today. 1996;26(4):225-9 PMID: 8727941
  3. Balance of inflammatory cytokines related to severity and mortality of murine sepsis.
    Infect Immun. 1996 Nov;64(11):4733-8 PMID: 8890233
  4. C5a-dependent up-regulation in vivo of lung vascular P-selectin.
    J Immunol. 1997 Feb 15;158(4):1857-61 PMID: 9029126
  5. Phosphotyrosine phosphatase activity in the macrophage is enhanced by lipopolysaccharide, tumor necrosis factor alpha, and granulocyte/macrophage-colony stimulating factor: correlation with priming of the respiratory burst.
    Biochim Biophys Acta. 1997 Mar 1;1355(3):343-52 PMID: 9061005
  6. Requirement for C-X-C chemokines (macrophage inflammatory protein-2 and cytokine-induced neutrophil chemoattractant) in IgG immune complex-induced lung injury.
    J Immunol. 1997 Apr 1;158(7):3439-48 PMID: 9120305
  7. Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement.
    J Immunol. 1997 Jul 15;159(2):976-82 PMID: 9218619
  8. Effects of anti-C5a monoclonal antibodies on oxygen use in a porcine model of severe sepsis.
    Eur J Clin Invest. 1998 Mar;28(3):227-34 PMID: 9568469
  9. Protective function of C6 in rabbits treated with bacterial endotoxin.
    J Immunol. 1971 Apr;106(4):1125-7 PMID: 5553714
  10. Host defense against bacterial endotoxemia-contribution of the early and late components of complement to detoxification.
    J Immunol. 1972 Oct;109(4):893-5 PMID: 4561474
  11. Acute immunologic pulmonary alveolitis.
    J Clin Invest. 1974 Aug;54(2):349-57 PMID: 4277008
  12. Remote organ failure: a valid sign of occult intra-abdominal infection.
    Surgery. 1977 Mar;81(3):310-3 PMID: 841468
  13. Incidence and outcome of the respiratory distress syndrome in gram-negative sepsis.
    Arch Intern Med. 1979 Aug;139(8):867-9 PMID: 464700
  14. Sepsis and septic shock--a review of laboratory models and a proposal.
    J Surg Res. 1980 Aug;29(2):189-201 PMID: 6997619
  15. The role of C5 in septic lung injury.
    Ann Surg. 1985 Dec;202(6):771-6 PMID: 4073989
  16. Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates.
    J Clin Invest. 1986 Jun;77(6):1812-6 PMID: 3711336
  17. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.
    J Immunol Methods. 1986 Dec 4;95(1):99-105 PMID: 3782828
  18. The gut origin septic states in blunt multiple trauma (ISS = 40) in the ICU.
    Ann Surg. 1987 Oct;206(4):427-48 PMID: 3116956
  19. Endotoxin-induced shock in the rat. A role for C5a.
    Am J Pathol. 1989 Sep;135(3):489-97 PMID: 2789475
  20. The complex pattern of cytokines in sepsis. Association between prostaglandins, cachectin, and interleukins.
    Ann Surg. 1991 Aug;214(2):141-8 PMID: 1867521
  21. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.
    Chest. 1992 Jun;101(6):1644-55 PMID: 1303622
  22. Polymicrobial sepsis selectively activates peritoneal but not alveolar macrophages to release inflammatory mediators (interleukins-1 and -6 and tumor necrosis factor).
    Circ Shock. 1992 Mar;36(3):191-9 PMID: 1611704
  23. Complement component C5 modulates the systemic tumor necrosis factor response in murine endotoxic shock.
    Infect Immun. 1993 Apr;61(4):1474-81 PMID: 8454352
  24. Tumor necrosis factor alpha regulates in vivo intrapulmonary expression of ICAM-1.
    Am J Pathol. 1993 Jun;142(6):1739-49 PMID: 7685152
  25. Regulation of macrophage TNF alpha, IL-1 beta, and Ia (I-A alpha) mRNA expression during peritonitis is site dependent.
    J Surg Res. 1993 May;54(5):426-30 PMID: 8361168
  26. The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failure.
    J Exp Med. 1994 Feb 1;179(2):569-78 PMID: 8294868
  27. Postinjury multiple organ failure: role of extrathoracic injury and sepsis in adult respiratory distress syndrome.
    New Horiz. 1993 Nov;1(4):538-49 PMID: 8087574
  28. Evolving concepts in the pathogenesis of postinjury multiple organ failure.
    Surg Clin North Am. 1995 Apr;75(2):257-77 PMID: 7899997
  29. Enhancement by the complement membrane attack complex of tumor necrosis factor-alpha-induced endothelial cell expression of E-selectin and ICAM-1.
    J Immunol. 1995 Aug 1;155(3):1434-41 PMID: 7543521
  30. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity.
    Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11490-4 PMID: 8524789
  31. Role for macrophage inflammatory protein-2 in lipopolysaccharide-induced lung injury in rats.
    J Immunol. 1996 Mar 1;156(5):1963-72 PMID: 8596051
  32. Inhibition of interleukin-6 synthesis in an animal model of septic shock by anti-C5a monoclonal antibodies.
    Eur J Immunol. 1996 May;26(5):1103-9 PMID: 8647174
  33. The sepsis syndrome. Definition and general approach to management.
    Clin Chest Med. 1996 Jun;17(2):175-81 PMID: 8792059
Article Info
Journal
The American journal of pathology
Abbr.
Am J Pathol
ISSN
0002-9440
Published
1999-04-00
Pages
1057-65
Language
English
Region
United States
NLM ID
0370502
PMCID
PMC1866577
Subset
IM
Grants
NHLBI NIH HHS · P01 HL031963 · United States
NHLBI NIH HHS · HL-31963 · United States
NIGMS NIH HHS · R37 GM029507 · United States
NIGMS NIH HHS · GM-29507 · United States
NIGMS NIH HHS · R01 GM029507 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]